Is there an Indian generic version of Giritinib?

Gilteritinib is a targeted therapy drug used to treat FLT3 mutation-positive acute myeloid leukemia (AML), especially for patients with relapsed or refractory AML. It belongs to the category of tyrosine kinase inhibitors. By inhibiting the activity of FLT3 receptor kinase, it blocks the proliferation and survival of leukemia cells, thereby achieving the purpose of treatment.

Although giritinib has been launched in the domestic market, unfortunately, it has not yet been included in the scope of medical insurance. Therefore, the domestic price remains high, as high as more than 20,000 yuan. For exact pricing information, please check with your local hospital or pharmacy.

At present, there are no generic giritinib drugs officially on the market in India, mainly the Lao version. The price is about two to three thousand yuan, which is far lower than the domestic market price. It is worth mentioning that the ingredients of these generic drugs are basically the same as our domestic original drugs.

In leukemia cells, the FLT3 receptor often mutates into an abnormally active form, leading to abnormal proliferation and survival of leukemia cells. The mechanism of action of giritinib is to selectively inhibit this abnormally active FLT3 receptor kinase, thereby reducing the proliferation and viability of leukemia cells. This makes geritinib an important treatment option, especially for patients with FLT3 mutation-positive AML, who often have a poor prognosis.

Although gilitinib has made significant progress in the treatment ofAML, several challenges and limitations remain. Some patients may develop drug resistance or treatment failure and need to seek other treatment options. In addition, the recurrence of leukemia is also a problem that requires vigilance during treatment, requiring close monitoring and timely intervention.

In general, giritinib, as a targeted therapy, has shown important clinical significance in the treatment ofAML. However, patients need to work closely with their doctors during use, follow medical instructions, and undergo regular monitoring and follow-up to ensure the effectiveness and safety of the treatment.